Drug Development
-
A Stanford Medicine-led study found that residual liver cancer cells interact with neighboring macrophages to prompt the disease to reappear.
-
‘Gut balls’ advance celiac research
Balls of intestinal cells from people with celiac disease faithfully model the disorder in a Stanford Medicine study. The lab-grown organoids revealed a new link between gluten and cell death.
-
Lymphoma therapy shows promise
In an early Stanford Medicine study, CAR-T cell therapy helps some with intractable lymphoma, but those who relapse have few options. Modifying the therapy’s molecular target improved response.
-
New compound supercharges naloxone
In a Stanford Medicine-led study, researchers combed through billions of compounds to find one that could enhance naloxone’s ability to fend off more potent opioids, with promising results in mice.
-
Gene therapy for neurologic disease
Experts at Stanford Medicine Children’s Health helped conduct clinical trials for the new therapy, which gives kids with X-linked adrenoleukodystrophy, or ALD, a functioning copy of the abnormal gene.
-
Blood pressure drug may prevent epilepsy
In an analysis of more than 2 million patient records, researchers discovered that people taking angiotensin receptor blockers for high blood pressure were less likely to develop epilepsy.
-
AI tackles antibiotic resistance
Stanford Medicine researchers devise a new artificial intelligence model, SyntheMol, which creates recipes for chemists to synthesize the drugs in the lab.
-
Drug ups production of anti-hunger molecule
A Stanford Medicine study found that metformin, a commonly prescribed diabetes drug associated with moderate weight loss, stimulates production of lac-phe, a molecule abundant after exercise.
-
Eye fluid study may foster treatments
Stanford Medicine researchers clock the age of cells to find new therapy targets.
-
William Robinson, pioneering virologist
Hard-driving molecular virologist who used ‘advanced chemistry to unlock the tightly held secrets of viruses’ was also a hearty mountain man, scaling peaks in Alaska and Nepal.
-
Nobelists credit basic research
A two-day event at the Stanford School of Medicine brought together investors, regulators, company executives and scientists to discuss the most productive ways for them to work together.
-
New COVID-19 vaccine
In a study led by Stanford Medicine researchers, a low-cost COVID-19 vaccine that does not require refrigeration provided immunity in rhesus monkeys for one year.
Related Websites
- Addiction
- Aging & Geriatrics
- Anesthesiology & Pain Management
- Animal Research
- Artificial Intelligence (AI)
- Autoimmune Conditions
- Biochemistry
- Bioengineering
- Blood Disorders (Hematology)
- Cancer
- Cardiology
- Cellular & Molecular Biology
- Community Programs
- Data Sciences
- Dermatology
- Diabetes
- Diversity, Equity & Inclusion
- Drug Development
- Ear Nose & Throat
- Emergency Medicine
- Endocrinology
- Environment & Sustainability
- Epidemiology & Population Health
- Ethics
- Genetics
- Global Health
- Health Policy
- Immunology
- Infectious Diseases
- Innovation & Technology
- Internal Medicine
- Kidney Health (Nephrology)
- Lung Health
- Maternal Health
- Men's Health
- Microbiology
- Neurobiology
- Neurology & Neurosurgery
- Nutrition
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedics
- Palliative Care
- Pathology
- Pediatrics
- Physiology
- Precision Health
- Preventive Medicine
- Primary Care
- Psychiatry & Mental Health
- Radiology
- Stanford Medicine
- Stem Cells
- Surgery
- Transplantation
- Urology
- Vaccines
- Wellness
- Women's Health